Glaukos Corporation

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
      • Controlled Release
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive

Other Names/Subsidiaries

  • Avedro, Inc.
  • DOSE Medical Corporation
See more in Biomedtracker

Latest on Glaukos Corporation

Scrip

Deal Watch: MacroGenics Offloads Margenza To TerSera As Focus Shifts To Pipeline

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MacroGenics Gets $40m Up Front For St

Scrip

Glaukos Gets Approval For Glaucoma Implant, With A Catch

 
• By Joseph Haas

Glaukos Corporation got US Food and Drug Administration approval of iDose TR, its intracameral implant of travoprost for glaucoma, on 14 December, but it appears the company’s regulatory work is only

Scrip

Deal Watch: Lilly Will Take Over Beam’s Rights To Verve Cardiovascular Assets

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With Verve Again By Acqu

Medtech Insight

LSI 2023: What Ophthalmology Start-Ups Pitched To Investors At Emerging Medtech Summit

 
• By Marion Webb

This year’s LSI Emerging Medtech Summit, held from 20-23 March, began in unusally cool, rainy weather for Dana Point, CA. But inside the posh Monarch Beach Resort the scene was cozier and abuzz with b